AWS and Accenture Collaborate with MSD to Accelerate Drug Discovery and Clinical Trial Development Using Cloud Technologies

And accelerate clinical trial development

BeijingDecember 6, 2023 /PR Newswire/ -- AWS in2023 re:InventAnnounced at the Global Conference the collaboration with Accenture to jointly assist MSD, a global leading biopharmaceutical company, in migrating the majority of...ITMSD's infrastructure migration to AWS will be part of a multi-year cloud migration project.

As part of the project, MSD has selected AWS as its preferred cloud service provider and Accenture as its professional services partner to jointly drive the migration of the company’s core applications, including...SAP, machine learning, and data warehouse migration to AWS, thereby accelerating MSD's progress in scientific research and discovery.

Self2021Since the year, MSD has been collaborating with AWS and Accenture to drive its value chain transformation and accelerate the cloud migration process. MSD is leveraging AWS's extensive and deep analytical services and artificial intelligence (AI) services, applying them to research, manufacturing, human health, animal health, and global support functions within the enterprise. For example, MSD uses a manufacturing platform built on AWS to help identify complex defects in the pharmaceutical process caused by limited training data, such as cracks or foreign objects. MSD also utilizes fully managed services for building, training, and deploying machine learning models.Amazon SageMaker, forHawkAVIThe manufacturing platform developed an inference pipeline and generated data from equipment across multiple manufacturing plants.TBExtracting insights from tiered data. Through generativeAIBy leveraging machine learning technology, MSD can accelerate the analysis of root causes, reduce false positives in rejection rates, and further enhance product availability and qualification rates.

In collaboration with Accenture, MSD has chosen AWS to enhance its high-performance computing (HPC) capability to accelerate the discovery of treatment methods. With the high-performance computing ( provided by AWS,HPC) Services as well as specifically built for biological insights and automationAmazon HealthOmicsService, MSD can expand the scale of its protein model prediction and omics analysis, and by runningHealthOmicsThe workflow of management is as follows:AlphaFold, to accelerate drug discovery. In addition, MSD will also integrate allSAPWorkload migration to AWS, includingSAP Business Warehouse、SAP HANA SidecarAndSAP Master Data Governance, to enhance system resilience and flexibly allocate resources according to business needs.

To support the company's overall business operations, MSD's cloud modernization initiative advances training, diversity, and employee development by introducing a new operational model, thereby enhancing the employee experience. MSD has also established an internal academy to provide employees with skills upgrading in cloud technology areas such as AWS services, further driving the company’s technological transformation.

In the future, the efficiency improvements brought by cloud migration will also help MSD reallocate resources to other strategic projects. AWS and Accenture have developed a systematic, value-driven framework based on data from previous modernization systems to track cost savings achieved in re-hosted, decommissioned, or modernized applications. This comprehensive framework enables teams to identify any application and pinpoint the exact savings generated by a specific operation. MSD has already achieved significant cost savings using this framework.ITOperating costs, these released resources can be used to support other strategic projects.

“MSD's goal is to ensure that drugs and vaccines reach customers and patients more quickly while maintaining our high standards of quality. Our collaboration with AWS and Accenture is helping us transform operations at every stage of the value chain.——From the discovery and development of treatment methods to delivery.”Executive Vice President and Chief Information and Digital Officer of MSDDave WilliamsExpressed as,“One of the huge advantages of migrating to AWS is that we are able to leverage generativeAI...and other technologies, make more data-driven decisions, thereby better meeting the needs of patients.”

“Machine Learning and GenerativeAIThe use of technology holds promise to accelerate innovation, enhance efficiency, boost the productivity of scientists and clinicians, streamline clinical processes, and thereby facilitate research, drug development, and scientific breakthroughs.”General Manager of Healthcare and Life Sciences at AWSDan SheeranIndicates,“We look forward to building on our long-term collaboration with MSD, helping them unlock the potential of scientific and health data, shorten the drug and clinical development cycle, and enhance the global accessibility of drugs and vaccines.”

“The collaboration among Accenture, AWS, and MSD will bring continuous success and create greater value for MSD’s global employees and patients. When our work results in saving more lives or improving patient health, it is an incredibly meaningful experience for us.”Senior Managing Director, Accenture Life Sciences Industry PracticeJason AndersonIndicates,“MSD's rapid corporate transformation is an excellent example of how the life sciences industry can respond to future great opportunities.——This transformation fully leverages the advantages of its system, integrating cloud strategy with enterprise business scenarios to generate greater economic benefits, while formulating a talent strategy aligned with the company’s growth objectives.”

About AWS

Self2006Since the year, AWS (Amazon Web Services) has always been renowned in the industry for its technological innovation, rich services, and wide applications. AWS continuously expands its service portfolio to support almost any workload in the cloud and currently offers over240A full range of services, covering computing, storage, databases, networking, data analytics, machine learning and artificial intelligence, Internet of Things, mobile, security, hybrid cloud, virtual reality and augmented reality, media, as well as application development, deployment, and management; infrastructure spans across32A geographical region102Availability Zone, and has announced plans to build new ones in Canada, Germany, Malaysia, New Zealand, and Thailand.5This area,15Availability Zone. Millions of customers worldwide, including fast-growing startups, large enterprises, and leading government agencies, trust AWS to support their infrastructure, increase agility, and reduce costs. To learn more about AWS, please visit:www.amazonaws.cn。

About Accenture

Accenture PLC, registered in Ireland, is a global leading professional services company that helps businesses, governments, and organizations across all sectors build digital core capabilities, optimize operations, accelerate revenue growth, enhance social service levels, and create tangible value faster and on a larger scale. Accenture adheres to the leadership of top talent and innovation, with approximately73.310,000 employees, serving in120Clients from multiple countries. Technology plays a key role in today's transformation. Accenture combines its industry-leading expertise and global delivery capabilities by integrating its technological advantages and leadership in cloud, data, and artificial intelligence, providing excellence in strategy and consulting, technical services, intelligent operations, and industrial solutions.XAndAccenture Song...and other fields to provide customers with comprehensive services and solutions. Accenture is committed to delivering exceptional service capabilities, a culture of shared success, and creating value for customers.360°The mission of value is to help customers achieve success and build long-term trust. Accenture also focuses on360°Value measures itself, creating a better future for customers, employees, shareholders, partners, and the entire society. For more information, please visitwww.accenture.com。

About MSD

We work together to pursue a common goal: harnessing the power of cutting-edge science to save lives and improve lives around the world.130For many years, we have brought hope to all humanity by researching and developing important drugs and vaccines. We are committed to becoming a leading research-intensive biopharmaceutical company.——Today, we are at the forefront of research and development, introducing innovative solutions to advance the prevention and treatment of diseases in humans and animals. We have built a diverse and inclusive global workforce, operating each day with responsibility to ensure a safe, sustainable, and healthy future for all people and communities. For more information, please visitwww.msd.com, and inX(OriginalTwitter)、Facebook、Instagram、YouTubeAndLinkedInPlatform follows us.